Blog – CIRCB

Tous

juin 12, 2026

Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-DefinedScenarios

Par Robert W. Shafer et al. ABSTRACT Introduction: Drug resistance testing may improve the management of people living with HIV(PLWH)inseveral scenarios in low- and middle-income countries […]

juin 12, 2026

Interest in long-acting injectable ART amongadolescents with perinatally acquired HIVin Cameroon: Implications for implementationin developing countries

Par Yagai Bouba et al. Abstract Long-acting injectable antiretroviral therapy (LAI-ART) has the potential to transform HIV treatment for adolescents with perinatal HIV infection (APHI). Given […]

juin 8, 2026

Clôture du projet CIPHER-ADOLA

Une session de dissémination et de clôtures des activités du projet CIPHER-ADOLA s’est tenue le mercredi 03 juin 2026 au Centre International de Référence Chantal Biya […]

mai 8, 2026

Initial detection of SARS-CoV-2 Omicron BA.4 and BA.5 sub variants associated with the onset of the fifth wave of COVID-19 in Cameroon between December 2021 and June 2022: phylogenetic and whole genome analysis

Par John Otokoye Ot et al. ABSTRACT Background: Two sub variants (BA.4 and BA.5) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant are […]

mai 8, 2026

Tenofovir and Doravirine Are Potential Reverse-TranscriptaseAnalogs in Combination with the New Reverse-TranscriptaseTranslocation Inhibitor (Islatravir) Among Treatment-ExperiencedPatients in Cameroon: Designing Future Treatment Strategies forLow- and Middle-Income Countries

Par Alex Durand Nka et al. Abstract Islatravir (ISL) is a novel antiretroviral that inhibits HIV-1 reverse transcriptase translocation. The M184V mutation, known to reduce ISL’s […]

mai 7, 2026

Pre-analytical errors during HIV viral load(HIV-VL) and early infant diagnosis (EID) testingin Cameroon

Par Marie Atsama-Amougou et al. Abstract Background: HIV Viral Load (HIV-VL) and Early Infant Diagnosis (EID) play a pivotal role in the laboratory surveillance, monitoring of […]

mai 7, 2026

Characteristics of occult hepatitis B infectionamong pregnant women in the Center Region ofCameroon: rationale for universal administrationof hepatitis B birth dose vaccine

Par Juliette-Laure Ndzie Ondigui et al. Abstract Introduction: Occult hepatitis B infection (OBI) among pregnant women poses a significant public health problem in the prevention of […]

mai 7, 2026

Molecular profiling of human papillomavirus genotypes, cytomorphologicalabnormalities, and their predictors in Cameroon:a multi-regional analysis

Par Keriane Diane Kambou Kountchou et al. Abstract Cervical cancer-related mortality remains high in Cameroon, yet data on high-risk human papillomavirus (HR-HPV) genotypes are sparse. This […]

mai 7, 2026

Efficacy of dolutegravir-based therapy inachieving virological suppression in PLHIV inlow- and middle-income countries: real-worldevidence from a large clinical cohort in Cameroon

Par Carine Tadenfok et al. ABSTRACT BACKGROUND: HIV treatment has significantly improved with the introduction of potent antiretroviral therapy (ART), particularly dolutegravir (DTG)-based regimens. With suboptimal […]